Phare Bio

Recent Finacing

Grant

Recent Raise

$27M

Phare Bio uses generative AI, ML and bioengineering with MIT and Wyss collaborators to design AI-generated antibiotics, create an open-source discovery database, and produce toxicology, metabolism and formulation data.

Founded 2020

1-10

Private

pharebio.org

Highlights

Focus Areas

Artificial Intelligence (AI)

Biotechnology

Recent Investors

Financials

$27M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Phare Bio.